The global interventional oncology devices market is an emerging market in the medical device ecosystem. The market comprises various key medical device companies and several start-ups developing advanced solutions for cancer treatment. Furthermore, the market also has unique products in the pipeline that would further improve the technology integration in cancer treatment. The major factors that have a positive impact on the market’s growth include high prevalence and growing incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in treatment of cancer, and availability of private and government funding for grants for research in the field of interventional oncology.
During COVID-19, the growth of the interventional oncology devices market was negatively impacted, especially in 2020. Although the interventional oncology facilities continued to operate, the sales of the companies were negatively impacted.
The global interventional oncology devices market report highlights that the market was valued at $2,429.2 million in 2020 and is expected to reach $7,861.1 million by the end of 2030. The market is expected to grow at a CAGR of 12.35% during the forecast period from 2021 to 2030.
Market Segmentation
Key Market Players and Competition Synopsis
Some of the key players operating in the market include AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Eckert & Ziegler BEBIG AG, HealthTronics, Inc., IceCure Medical Ltd, Johnson & Johnson, Medtronic plc, MedWaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sonablate Corp, Terumo Corporation, Trod Medical, and Varian Medical Systems, Inc.
Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been mergers and acquisitions followed by regulatory and legal activities.
Global Interventional Oncology Devices Market Drivers
The factors driving the growth of the market include the high prevalence and growing Incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in the treatment of cancer, availability of private and government funding and grants for research in the field of interventional oncology. The field of interventional oncology is constantly evolving with the introduction of novel technologies. Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.
Thus, as the prevalence of cancer continues to increase, especially in emerged economies, technology adoption will continue to grow. This will consequently advance the growth of interventional oncology and, subsequently, the global market.
Global Interventional Oncology Devices Market Challenges
The factors restraining the growth of the global interventional oncology devices market include the financial burden of product recalls, the lack of clinical evidence for locoregional treatments, and the dearth of trained interventional oncologists. Shortage of clinical data and increasing incidences of serious side effects associated with the use of interventional oncology devices have led to numerous instances of interventional oncology device product recalls that are critically hindering the growth of the interventional oncology devices market.
Another major restraint for the global interventional oncology devices market is the shortage of skilled interventional oncology professionals in most countries who can perform interventional oncology procedures. The situation continues to worsen, as cancer is rising faster than the rate at which new interventional oncologists are entering the field.
Global Interventional Oncology Devices Market Opportunities
High growth opportunities in the emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global interventional oncology devices market growth.
There is massive scope for interventional oncology devices in developing countries. Countries such as China, India, Australia, and South Korea possess populations with high prevalence and incidence rates of cancer, which drives the adoption of interventional oncology devices for the treatment of cancer, which would surge the overall interventional oncology devices market in these emerging countries.
Get Free Sample Report- https://bisresearch.com/requestsample?id=1215&type=download
How This Report Can Add Value
Assuming that the reader is a manufacturer of interventional oncology devices market, they will be able to do the following:
• Understand their position compared to some of the key players in the market
• Stay updated with novel technology integration, features, and the latest developments in the market
• Understand the impact of COVID-19 on the adoption of interventional oncology devices and the entry barriers because of it
• Gain insights into end-user perception with respect to the adoption of interventional oncology
• Identify some of the key players in the market and understand their valuable contribution
Key Questions Answered in the Global Interventional Oncology Devices Market Report
• What are the key trends that have a strong influence on the global interventional oncology devices market? How did the COVID-19 pandemic impact the growth of the interventional oncology devices market?
• What are the key development strategies which are implemented by the key players to maintain and capture market share?
• How does the patent landscape of interventional oncology devices look like?
• What are the major market drivers, challenges, and opportunities in the global interventional oncology devices market?
• Which leading companies are dominating the global interventional oncology devices market?
• What are the regulations about the global interventional oncology devices market? What are the initiatives implemented by different government bodies to reduce the cancer rate?
• What was the market value of the leading segments and sub-segments of the global interventional oncology devices market?
• How is each segment of the global interventional oncology devices market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segments by the end of 2030?
• Which region carries the potential for the significant expansion of key companies for the interventional oncology devices market?
BIS Related Studies
Global Radiation Dose Management Market
Global Radiofrequency-Based Devices Market
Global Radiation Therapy Quality Assurance (QA) Phantoms Market
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reportsThe Interventional Oncology Devices Global Market Report 2020-30 by The Business Research Company describes and explains the global interventional oncology devices market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.
The report evaluates the market across each region and for the major economies within each region.The Interventional Oncology Devices Global Market Report 2021 covers interventional oncology devices market drivers, interventional oncology devices market trends, interventional oncology devices market segments, interventional oncology devices market growth rate, interventional oncology devices market major players, and interventional oncology devices market size.View Complete Report: https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report-2020-30-covid-19-growth-and-changeThe interventional oncology devices market report provides an in-depth analysis of the impact of COVID-19 on the global interventional oncology devices industry, along with revised market numbers due to the effects of the coronavirus and the expected interventional oncology devices market growth numbers 2021-2030.Interventional Oncology Devices Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now:https://www.thebusinessresearchcompany.com/sample.aspx?id=3304=smpThe global interventional oncology devices market is expected to grow from $2.015 billion in 2020 to $2.234 billion in 2021 at a compound annual growth rate (CAGR) of 10.9%.
The market is expected to reach $3.32 billion in 2025 at a CAGR of 10%.The report covers the interventional oncology device market segments-1) By Product: Embolization Devices, Ablation Devices, Support Devices.2) By Procedure: Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) Or Bland Embolization.3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Others.About The Business Research Company: The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research.
It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally.
